Linezolid Dosing Strategies in Drug-Resistant TB

Clinical trial NCT05007821 · COMPLETED

Trial details

NCT number: NCT05007821
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Tuberculosis, Multidrug-Resistant Tuberculosis Tuberculosis, Pulmonary

Start date: 2022-09-27
Primary completion: 2025-03-14
Enrollment: 138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.